21![Rationale for the EUCAST clinical breakpoints Rationale for the EUCAST clinical breakpoints](https://www.pdfsearch.io/img/a016ca12eb571522c381eb2e2cdc2188.jpg) | Add to Reading ListSource URL: www.eucast.orgLanguage: English - Date: 2011-05-09 01:45:41
|
---|
22![Rationale for the EUCAST clinical breakpoints Rationale for the EUCAST clinical breakpoints](https://www.pdfsearch.io/img/5b5e9cdc638d6fef3ddf8d8939fe7aa1.jpg) | Add to Reading ListSource URL: www.eucast.orgLanguage: English - Date: 2012-01-17 07:37:04
|
---|
23![Rationale for the EUCAST clinical breakpoints Rationale for the EUCAST clinical breakpoints](https://www.pdfsearch.io/img/0a279f22b48375306f814daebf2eb93e.jpg) | Add to Reading ListSource URL: www.eucast.orgLanguage: English - Date: 2012-06-06 13:49:57
|
---|
24![Noxafil To Initiate a Coverage Review, call[removed] Posaconazole (Noxafil) Noxafil To Initiate a Coverage Review, call[removed] Posaconazole (Noxafil)](https://www.pdfsearch.io/img/82578e555baf7391e159270b141ddb5d.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-01-29 12:46:57
|
---|
25![----------------------- WARNINGS AND PRECAUTIONS ---------------------- • Calcineurin Inhibitor Toxicity: Noxafil increases concentrations of cyclosporine or tacrolimus; reduce dose of cyclosporine and tacrolimus an ----------------------- WARNINGS AND PRECAUTIONS ---------------------- • Calcineurin Inhibitor Toxicity: Noxafil increases concentrations of cyclosporine or tacrolimus; reduce dose of cyclosporine and tacrolimus an](https://www.pdfsearch.io/img/fdba4f97c1350007dae117720188e8fa.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-11-26 15:13:17
|
---|
26![F-XXXXXXXX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NOXAFIL ORAL SUSPENSION safely and effectively. See full prescribing information for NOXAFIL ORAL SUSPENS F-XXXXXXXX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NOXAFIL ORAL SUSPENSION safely and effectively. See full prescribing information for NOXAFIL ORAL SUSPENS](https://www.pdfsearch.io/img/e18da02038932db10b85fe1f2f904af6.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-09-09 19:11:22
|
---|
27![CANADIAN ANTIMICROBIAL RESISTANCE ALLIANCE MEDIA BRIEF ON ANTIFUNGAL AGENTS Authored by Dr. Coleman Rotstein Fungi are eukaryotic organisms that are not amenable CANADIAN ANTIMICROBIAL RESISTANCE ALLIANCE MEDIA BRIEF ON ANTIFUNGAL AGENTS Authored by Dr. Coleman Rotstein Fungi are eukaryotic organisms that are not amenable](https://www.pdfsearch.io/img/36bc76c55b27c3f0e9a2cd03f9156825.jpg) | Add to Reading ListSource URL: www.can-r.comLanguage: English - Date: 2014-02-24 11:18:11
|
---|
28![CANADIAN ANTIMICROBIAL RESISTANCE ALLIANCE AZOLES FOR THE TREATMENT OF INVASIVE FUNGAL INFECTIONS Authored by Dr. Daniel Thirion CANADIAN ANTIMICROBIAL RESISTANCE ALLIANCE AZOLES FOR THE TREATMENT OF INVASIVE FUNGAL INFECTIONS Authored by Dr. Daniel Thirion](https://www.pdfsearch.io/img/3755e759e700ccf6e4617b68cd18536e.jpg) | Add to Reading ListSource URL: www.can-r.comLanguage: English - Date: 2014-02-24 11:18:11
|
---|
29![Chemistry / Organofluorides / Alcohols / Triazoles / Fusarium / Voriconazole / Fusariosis / Posaconazole / Fungal keratitis / Antifungals / Microbiology / Biology Chemistry / Organofluorides / Alcohols / Triazoles / Fusarium / Voriconazole / Fusariosis / Posaconazole / Fungal keratitis / Antifungals / Microbiology / Biology](/pdf-icon.png) | Add to Reading ListSource URL: www.hopkinsmedicine.orgLanguage: English |
---|
30![doi:[removed]j.ejcsup[removed] doi:[removed]j.ejcsup[removed]](https://www.pdfsearch.io/img/270378a55ecb2d2cda9dbfcbce730163.jpg) | Add to Reading ListSource URL: www.mycology.adelaide.edu.auLanguage: English - Date: 2010-12-01 01:14:15
|
---|